<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02416583</url>
  </required_header>
  <id_info>
    <org_study_id>SWP_PG_N2</org_study_id>
    <nct_id>NCT02416583</nct_id>
  </id_info>
  <brief_title>Concurrent Oxytocin With Membrane Sweeping Versus Dinoprostone Pessary in Labor Induction of Nulliparas at Term</brief_title>
  <official_title>Concurrent Oxytocin With Membrane Sweeping Versus Dinoprostone Pessary in Labor Induction of Nulliparas at Term</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare concurrent oxytocin with membrane sweeping versus dinoprostone pessary in labor
      induction for nulliparas at term with an unfavorable cervix
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vaginal delivery within 24 hours</measure>
    <time_frame>From the time of initiating intervention (i.e.concurrent membrane sweeping with dinoprostone or only dinoprostone) until the time of vaginal delivery, assessed up to 24 hours</time_frame>
    <description>Vaginal delivery within 24 hours is defined as vaginal delivery after 24 hours of initiating intervention (i.e.concurrent membrane sweeping with dinoprostone or only dinoprostone) on the first day of induction.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Successful labor induction</measure>
    <time_frame>From the time of initiating intervention (i.e.concurrent membrane sweeping with dinoprostone or only dinoprostone) until the time of active phase of labor ( defined as a cervical dilatation of &gt;=4cm), assessed up to 24 hours</time_frame>
    <description>to achieve the active phase of labor corresponding to a cervical dilatation of &gt;=4cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of cesarean delivery</measure>
    <time_frame>End of labor induction (assessed up to 120 hours)</time_frame>
    <description>From the time of initiating intervention (i.e.concurrent membrane sweeping with dinoprostone or only dinoprostone) until the time of cesarean delivery, assessed up to 120 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The interval from start of oxytocin to delivery</measure>
    <time_frame>From the time of initiating oxytocin infusion until the time of delivery, assessed up to 120 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Failed Induction of Labor</condition>
  <arm_group>
    <arm_group_label>Oxytocin &amp; Membrane sweeping</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Women assigned to &quot;Concurrent oxytocin with membrane sweeping&quot; had their cervix swept by inserting the examining finger as high as possible past the internal cervical os, followed by oxytocin infusion the next day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxytocin &amp; Dinoprostone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>For women assigned to &quot;Concurrent oxytocin with dinoprostone vaginal insert&quot;: The 10mg dinoprostone vaginal insert were placed in the posterior fornix for cervical ripening, followed by oxytocin infusion the next day</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxytocin</intervention_name>
    <arm_group_label>Oxytocin &amp; Membrane sweeping</arm_group_label>
    <arm_group_label>Oxytocin &amp; Dinoprostone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dinoprostone</intervention_name>
    <arm_group_label>Oxytocin &amp; Dinoprostone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Membrane sweeping</intervention_name>
    <arm_group_label>Oxytocin &amp; Membrane sweeping</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  singleton pregnancy

          -  Nulliparous women

          -  gestational age &gt;=37.0 weeks

          -  Bishop score &lt;=6

          -  intact amniotic membrane

          -  absence of labor

          -  live fetus with vertex presentation

          -  no previous uterine surgical procedure

        Exclusion Criteria:

          -  Multiple pregnancy

          -  Placenta previa
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyo Hoon Park, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kyo Hoon Park, MD, PhD</last_name>
    <phone>82-31-787-7252</phone>
    <email>pkh0419@snubh.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyo Hoon Park, MD, PhD</last_name>
      <phone>82-31-787-7252</phone>
      <email>pkh0419@snubh.org</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2015</study_first_submitted>
  <study_first_submitted_qc>April 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2015</study_first_posted>
  <last_update_submitted>February 14, 2017</last_update_submitted>
  <last_update_submitted_qc>February 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Kyo Hoon Park, MD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>membrane sweeping</keyword>
  <keyword>dinoprostone</keyword>
  <keyword>nulliparas</keyword>
  <keyword>labor induction</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
    <mesh_term>Dinoprostone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

